ERSOT
NKTR icon

Employees Retirement System of Texas’s Nektar Therapeutics NKTR Stock Holding History

Employees Retirement System of Texas’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,410
Closed -$423K – 760
2021
Q1 		$423K Hold
1,410
– – 0.01% 713
2020
Q4 		$360K Hold
1,410
– – 0.01% 626
2020
Q3 		$351K Hold
1,410
– – 0.01% 687
2020
Q2 		$490K Sell
1,410
-16,791
-92% -$5.24M 0.01% 698
2020
Q1 		$4.87M Buy
18,201
+1,791
+11% +$554K 0.09% 240
2019
Q4 		$5.31M Hold
16,410
– – 0.08% 288
2019
Q3 		$4.48M Buy
16,410
+8,810
+116% +$3.23M 0.07% 327
2019
Q2 		$4.06M Sell
7,600
-1,133
-13% -$568K 0.06% 351
2019
Q1 		$4.4M Buy
8,733
+6,800
+352% +$4.03M 0.07% 345
2018
Q4 		$953K Buy
1,933
+1,200
+164% +$724K 0.02% 802
2018
Q3 		$671K Buy
+733
New +$626K 0.01% 937
2018
Q2 		– Sell
-1,467
Closed -$2.34M – 1089
2018
Q1 		$2.34M Sell
1,467
-3,666
-71% -$4.72M 0.03% 576
2017
Q4 		$4.6M Sell
5,133
-534
-9% -$316K 0.06% 399
2017
Q3 		$2.04M Hold
5,667
– – 0.03% 630
2017
Q2 		$1.66M Hold
5,667
– – 0.02% 688
2017
Q1 		$2M Sell
5,667
-3,266
-37% -$734K 0.03% 642
2016
Q4 		$1.64M Hold
8,933
– – 0.02% 690
2016
Q3 		$2.3M Hold
8,933
– – 0.03% 562
2016
Q2 		$1.91M Buy
8,933
+4,066
+84% +$909K 0.03% 594
2016
Q1 		$1M Hold
4,867
– – 0.01% 749
2015
Q4 		$1.23M Sell
4,867
-2,400
-33% -$494K 0.02% 695
2015
Q3 		$1.2M Buy
+7,267
New +$1.29M 0.02% 719

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Employees Retirement System of Texas's NKTR Position: Q2 2021 in Review

Employees Retirement System of Texas sold out of Nektar Therapeutics (NKTR) in Q2 2021, closing a stake of 1,410 shares — an estimated $423K sold.

Employees Retirement System of Texas first reported a position in NKTR in Q3 2015 and held it in 22 quarters. The position peaked at $5.31M in Q4 2019. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2021.

  • Employees Retirement System of Texas reported no remaining Nektar Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Employees Retirement System of Texas sold 1,410 Nektar Therapeutics shares in Q2 2021, an estimated $423K.
  • Employees Retirement System of Texas first reported a position in Nektar Therapeutics in Q3 2015 and held it in 22 quarters.
  • Employees Retirement System of Texas's Nektar Therapeutics position peaked at $5.31M in Q4 2019.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2021.

Based on Employees Retirement System of Texas's 13F filing for Q2 2021, filed 10 Aug 2021.